Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy

26 Dec 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ocular Disorders and Treatments
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36581191
DOI: 10.1016/j.ajo.2022.12.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide TherapyPMID 36581191Read ↗

Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta ExperienceSemantic proximity Read ↗

Gene therapy for choroideremia: progress, potential and pitfallsSemantic proximity Read ↗

Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirusSemantic proximity Read ↗

AAV vectors: The Rubik’s cube of human gene therapySemantic proximity Read ↗

Adeno-Associated Viral Gene Therapy for Inherited Retinal DiseaseSemantic proximity Read ↗

Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerationsSemantic proximity Read ↗

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremiaSemantic proximity Read ↗

Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directionsSemantic proximity Read ↗

Molecular Therapies for ChoroideremiaSemantic proximity Read ↗

Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal DegenerationSemantic proximity Read ↗

Antisense Oligonucleotides: Treatment Strategies and Cellular InternalizationSemantic proximity Read ↗

Clinical utility gene card for: choroideremia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.